Quick Start to Treatment of Opioid Use Disorders: Buprenorphine Focus Course - Enduring Webinar

The Wisconsin Society of Addiction Medicine hosted the Quick Start to Treatment of Opioid Use Disorders: Buprenorphine Focus Course webinar on Thursday, August 15 from 12:30-2:30 p.m.

This course was created by WISAM, in order to provide Primary Care Providers who are interested in treating opioid use disorders the opportunity to learn more and ask questions. 

Speakers:

• Ritu Bhatnagar, MD, MPH
  
• Ezra Lyon, MD

Learning Objectives:
At the end of the course, the participant will be able to:

• Explain the role of medications in the treatment of opioid use disorder (OUD)
• Describe pharmacology of buprenorphine
• Describe use of buprenorphine in OUD treatment from office-based setting
• Understand how to manage common concerns in the treatment of OUD
• Consider role of buprenorphine in their practice

WISAM is offering Enduring CME for this training until August 15, 2025. Register and you will receive a link to the webinar recording and CME instructions.

____________________________________________________________________________

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and WISAM.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.

Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity / enduring materials for a maximum of 2.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.